SI-BONE, Inc. (SIBN) stock
Close on Nov 13, 2026Market cap $1.05BP/E –Yield 0.00%
SI-BONE, Inc. grew revenue 15.3% to $213.60M over the twelve months to Jun 30, 2026. Free cash flow was -$4.39M. At the latest close the market valued the company at $1.05B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.05B
- P/E ratio
- –
- Price to sales
- 4.92
- Price to book
- 5.76
- Dividend yield
- 0.00%
- Free cash flow yield
- -0.42%
Fundamentals
- Revenue
- $213.60M
- Net income
- -$14.63M
- EPS, diluted
- -$0.34
- Free cash flow
- -$4.39M
- Book value per share
- $4.10
- Diluted shares
- 44M
Trading
- Next earnings
- Feb 22, 2027 (estimated, after the close)
- Previous close
- $24.14
- Open
- $24.40
- Day's range
- $23.40 – $24.68
- Volume
- 443,692
- Average volume (20 days)
- 933,475
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 0.80
- 52-week range
- $11.48 – $25.92
- RSI (14 days)
- 56.4
- Volatility (1 year)
- 50.2%
- Relative volume
- 0.70×
- WACC
- 9.0%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2018, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | SIBN | S&P 500 | Difference | SIBN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +19.1% | -3.0% | +22.1 pts | ||
| 3 months | +23.7% | -2.8% | +26.5 pts | ||
| Year to date | +18.9% | +11.5% | +7.4 pts | ||
| 1 year | +35.8% | +13.5% | +22.3 pts | ||
| 3 years | +47.1% | +77.7% | −30.6 pts | +13.7% | +21.1% |
| 5 years | +6.1% | +72.6% | −66.5 pts | +1.2% | +11.5% |
| 10 years | +234300.0% | +308.2% | +233991.8 pts | +117.3% | +15.1% |
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Si-Bone filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Si-Bone
Surgical & Medical Instruments & Apparatus
The medical device company develops procedural implants and surgical instruments for patients with compromised bone, focusing on sacroiliac joint dysfunction, spinal deformity, and pelvic trauma. Its main offerings include the iFuse line of titanium and 3D-printed implants, such as iFuse 3D, iFuse TORQ, iFuse Bedrock Granite, and iFuse TORQ TNT, alongside human bone allograft products. The company's customer base consists of healthcare professionals, primarily orthopedic spine surgeons, neurosurgeons, orthopedic trauma surgeons, and interventional spine physicians.
Company profile, executives and historySi-Bone stock: common questions
What is Si-Bone's stock price?
SIBN closed at $23.44 on Nov 13, 2026, down 2.90% on the day. Over the past 52 weeks it traded between $11.48 and $25.92.
What is Si-Bone's market cap?
Si-Bone was worth $1.05B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is SIBN's P/E ratio?
Si-Bone lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.34), so it has no meaningful P/E ratio.
How much revenue does Si-Bone make?
Si-Bone reported revenue of $213.60M for the twelve months to Jun 30, 2026, up 15.3% from a year earlier.
Does Si-Bone pay a dividend?
No. Si-Bone has not paid a cash dividend over the last twelve months.
When does Si-Bone report earnings next?
Si-Bone is expected to report Q4 FY2026 results on Feb 22, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has SIBN stock performed over the past year?
Including dividends, SIBN returned +35.8% over the past year, against +13.5% for the S&P 500.
How many SIBN shares are sold short?
5M shares were sold short at the latest FINRA report, 10.49% of the float, or 6.8 days of average trading volume.
Who are Si-Bone's competitors?
Companies most similar to Si-Bone by business, industry and size include XTNT, KIDS, TMCI, BVS, SI.
See a number that looks wrong?